Novo Nordisk has appointed U.S. pharmaceutical executive Greg Miley as its new global head of corporate affairs, as the obesity drugmaker faces growing pressure from U.S. President Donald Trump on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback